
|Videos|December 15, 2016
Metastatic Non-Small Cell Lung Cancer with Alexander Drilon, MD: Case 2
Metastatic Non-Small Cell Lung Cancer with Alexander Drilon, MD
Advertisement
Case Scenario 2:
SR is a 58 year-old female, former smoker 20 PPY (stopped smoking 5 years ago), presents with cough and SOB. She experienced an unintended 10 lb weight loss over a 3-month period.
- Tissue analysis identified adenocarcinoma, EGFR, ALK, ROS1 negative.
- PD-L1 expression was < 50%.
- Patient has stage IV disease with metastasis to the liver.
- A chest CT scan confirmed the primary mass in the upper lobe of the right lung, with several pleural metastases and malignant pleural effusion.
- MRI of the brain was negative for intracranial metastases.
- Patient has not complained of blood in the sputum.
- Patient has history of well controlled HTN.
- Her performance status was 1 at diagnosis.
Patient was started on carboplatin/paclitaxel/bevacizumab for 4 cycles. Patient showed partial response and was continued on bevacizumab until progression.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
Nadunolimab Misses Efficacy Mark in TNBC, Despite Strong OS
3
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
4
Giredestrant/Everolimus Improves PFS Across Subgroups After CDK4/6i in ER+/HER2– Breast Cancer
5






































